REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & NephewAnnouncement

23/02/2022 09:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220223:nRSW5561Ca&default-theme=true

RNS Number : 5561C  Smith & Nephew Plc  23 February 2022

SMITH & NEPHEW PLC

 

23 February 2022

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

Smith & Nephew plc (the "Company") announces that it has been informed of
changes to the share interests of PDMRs in the Company, detailed below,
following completion of the related performance periods.

 

Smith & Nephew Global Share Plan 2010 (Performance Share Awards):

 

The following relates to individuals included in the below notification:

 

 Reason for the notification
 Initial notification /Amendment                              Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Smith & Nephew plc
 LEI                                                          213800ZTMDN8S67S1H61
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the financial instrument, type of instrument  Smith & Nephew plc ordinary shares of USD 0.20 each

 Identification code                                          ISIN: GB0009223206
 Nature of the transaction                                    Lapse of a Performance Share Award granted on 7 March 2019 under the Smith
                                                              & Nephew Global Share Plan 2010
 Date of Transaction                                          2022 - 02 - 22
 Place of Transaction                                         Lapse took place outside a trading venue

 

 Name of PDMR                                                                Number of ordinary shares under award granted on 07/03/2019 (shown at maximum)  Number of ordinary shares lapsed under award (shown at maximum)  Number of ordinary shares outstanding under award (shown at maximum)

 (Position)
 Helen Barraclough                                                           12,054                                                                          12,054                                                           0

 (Group General Counsel)
 Bradley Cannon                                                              30,784                                                                          30,784                                                           0

 (President, Orthopaedics, Sports Medicine & ENT and Americas)
 Phil Cowdy                                                                  22,564                                                                          22,564                                                           0

 (Chief Business Development & Corporate Affairs Officer)
 Simon Fraser                                                                27,166                                                                          27,166                                                           0

 (President, Advanced Wound Management & Global Commercial Operations)
 Elga Lohler                                                                 26,722                                                                          26,722                                                           0

 (Chief HR Officer)
 Vasant Padmanabhan                                                          26,382                                                                          26,382                                                           0

 (President, Research & Development)
 Susan Swabey                                                                9,784                                                                           9,784                                                            0

 (Company Secretary)

 

Notes:

 

(i)      Following completion of the performance measurement period,
these awards lapsed in full on 22 February 2022.

 

(ii)     Details regarding the performance against targets as set at the
grant date will be disclosed within the Annual Report which is to be published
on 7 March 2022.

 

This announcement is made in accordance with the requirements of Article 19
(3) of the Market Abuse Regulation.

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

Tel:      +44 (0) 1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFIFETFLIVFIF